IE Dublin Miinalainen I: Difference between revisions
From Bioblast
No edit summary |
No edit summary Β |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{ | {{O2k-Network Lab | ||
|institution=NICB | |institution=NICB | ||
Line 10: | Line 10: | ||
|MiPNetLab=Miinalainen Ilkka | |MiPNetLab=Miinalainen Ilkka | ||
|Status=O2k 2008-2013 | |Status=O2k 2008-2013 | ||
|info=[ | |info=[[MiPNet13.04 IOC47|IOC47]] | ||
|Info=[http://www.oroboros.at/index.php?id=1244 IE_Dublin_MiinalainenI] | |Info=[http://www.oroboros.at/index.php?id=1244 IE_Dublin_MiinalainenI] | ||
}} | }} | ||
== Feedback == | |||
* ''First of all IΒ΄d like to say that IΒ΄m very happy with the O2k system. I have used it quite a lot lately, mainly doing phosphorylation control titrations with intact podocytes and I have not have any problems, except for a few small ones relating to software.'' -Β '''[[Miinalainen IJ|Ilkka J Miinalainen]]''' (2009) |
Latest revision as of 09:49, 10 June 2016
IE Dublin Miinalainen I
O2k-Network Lab | NICB
Centre for Bioanalytical Sciences (CBAS) Dublin City University |
---|---|
Address | Glasnevin, |
City | Dublin |
State/Prov | |
Country | Ireland |
Weblink | |
Contact | |
Team | Miinalainen Ilkka |
Team previous | |
Status | O2k 2008-2013 |
Oroboros Events | IOC47 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Raesaenen 2016 Proc Natl Acad Sci U S A | 2016 | RΓ€sΓ€nen M, Degerman J, Nissinen TA, Miinalainen I, KerkelΓ€ R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, KivelΓ€ R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A 113:13144-49. |
O2k-Abstracts
update please
Feedback
- First of all IΒ΄d like to say that IΒ΄m very happy with the O2k system. I have used it quite a lot lately, mainly doing phosphorylation control titrations with intact podocytes and I have not have any problems, except for a few small ones relating to software. - Ilkka J Miinalainen (2009)